THE MBL77 DIARIES

Deep, focused upcoming-technology sequencing has disclosed that subclonal mutations (i.e., those current in just a fraction of tumor cells) may be detected for all driver genes and so are related to rapid disorder progression and poor final result.11–13 This is particularly relevant for TP53 mutations provided The truth that, as described under,